Bio-Techne Corp (TECH) Social Stream
BIO-TECHNE CORP (TECH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering TECH.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 9 | $600 | $400 | $510.625 | $80.85 | 531.57% |
| 2021-12-01 | 9 | $600 | $400 | $511.875 | $80.85 | 533.12% |
| 2022-02-01 | 9 | $600 | $400 | $506.25 | $80.85 | 526.16% |
| 2022-03-01 | 6 | $600 | $540 | $565 | $80.85 | 598.82% |
| 2022-04-25 | 7 | $600 | $370 | $532.5 | $80.85 | 558.63% |
| 2022-05-05 | 7 | $575 | $370 | $515.833 | $80.85 | 538.01% |
| 2022-06-06 | 7 | $575 | $370 | $506.428 | $80.85 | 526.38% |
| 2022-08-04 | 6 | $580 | $370 | $507.142 | $80.85 | 527.26% |
| 2022-08-05 | 6 | $580 | $370 | $491.428 | $80.85 | 507.83% |
| 2022-09-22 | 6 | $580 | $360 | $490 | $80.85 | 506.06% |
| 2022-10-19 | 6 | $550 | $360 | $485.714 | $80.85 | 500.76% |
| 2022-11-01 | 6 | $550 | $360 | $477.142 | $80.85 | 490.16% |
| 2022-11-02 | 6 | $500 | $360 | $442.5 | $80.85 | 447.31% |
| 2022-12-05 | 6 | $125 | $90 | $110.625 | $80.85 | 36.83% |
| 2022-12-07 | 7 | $125 | $89 | $108.222 | $80.85 | 33.86% |
| 2022-12-12 | 8 | $125 | $89 | $107.4 | $80.85 | 32.84% |
| 2023-01-06 | 9 | $125 | $89 | $106.727 | $80.85 | 32.01% |
| 2023-01-24 | 9 | $125 | $89 | $106.727 | $80.85 | 32.01% |
The Trend in the Analyst Price Target
Over the past 38 weeks, TECH's average price target has gone down $409.11.
TECH reports an average of 33.79% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-05 | 7 | 575 | 370 | 513.571 | 386.15 | 33% |
| 2022-07-14 | 6 | 580 | 370 | 507.142 | 341.39 | 48.55% |
| 2022-11-02 | 6 | 500 | 360 | 442.500 | 297.95 | 48.51% |
| 2022-12-07 | 7 | 125 | 89 | 108.222 | 80.67 | 34.15% |
| 2023-01-24 | 9 | 125 | 89 | 106.727 | 80.15 | 33.16% |
TECH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.44 | 7 | 0 | 2 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
TECH's average broker recommendation rating worsened by 0.44 over the prior 44 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, BIO-TECHNE CORP's average analyst price target is higher than 2323.04% of them.
- BIO-TECHNE CORP's upside potential (average analyst target price relative to current price) is greater than 2305.11% of stocks in the large market cap category.
- In terms of how BIO-TECHNE CORP fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is higher than 355.61% of that group.
- BIO-TECHNE CORP's variance in analysts' estimates is lower than -456.47% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, RGEN, AMGN, and DNA are the three stocks most similar to BIO-TECHNE CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for TECH? Use POWR Ratings for clearer insight into price direction.